Terfamex is a prescription medication designed for short-term obesity management. It contains phentermine, an appetite suppressant that aids in reducing caloric intake. Popular in regions like Mexico, Terfamex is primarily used by individuals struggling with weight loss despite lifestyle interventions like diet and exercise. This review covers its usage, benefits, side effects, and precautions. How […]
Acxion is a popular weight loss medication widely used in Mexico. It contains phentermine, a stimulant that works as an appetite suppressant. Unlike similar medications in the U.S., Acxion is more accessible without stringent prescription requirements, making it a go-to choice for individuals looking for a short-term weight loss solution. How Acxion Works The active […]
Imcivree (setmelanotide) is a melanocortin receptor agonist specifically approved for the treatment of obesity due to rare genetic conditions such as pro-opiomelanocortin (POMC) deficiency, proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiency, and leptin receptor (LEPR) deficiency. It is the first and only approved therapy targeting these specific genetic causes of severe obesity, making it an […]
Xultophy is a combination therapy specifically designed for adults with type 2 diabetes. It merges two active ingredients: insulin degludec, a long-acting insulin, and liraglutide, a GLP-1 receptor agonist, to deliver improved glycemic control. This once-daily injectable is prescribed as an adjunct to diet and exercise to enhance blood sugar regulation and is especially […]
Saxenda (liraglutide) is a prescription medication designed to aid in chronic weight management for adults with obesity or overweight individuals who have weight-related medical conditions. This injectable medication, which is administered once daily, works as part of a comprehensive Mechanism of Action Saxenda is a GLP-1 receptor agonist (glucagon-like peptide-1), a class of drugs that […]
Victoza (liraglutide) is a prescription medication designed to improve blood sugar control in adults and children aged 10 years and older with type 2 diabetes. It is part of a class of drugs known as GLP-1 receptor agonists and has additional cardiovascular benefits for certain high-risk patients. Administered via once-daily subcutaneous injection, Victoza helps patients […]